Newsroom - TRB

Filtrer par

COVID-19, how we adapt and respond to the situation.

Learn More

New publication of a large French clinical trial evaluating Ostenil Plus in osteoarthritis

Learn More

TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More

TRB Pharma Brazil awarded the Cândido Fontoura Necklace of Pharmaceutical Industry Merit

Learn More

The MEIN AUGE reminder mobile application for your eye drops is now available

Learn More

You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.

As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.

CONTINUE

TRB AT A GLANCE

TRB WORLDWIDE

HISTORY

OPHTHALMOLOGY

RHEUMATOLOGY

NEUROLOGY

HYALURONIC ACID

DIACEREIN

GM1 GANGLIOSIDE

TRB CHEMEDICA VOUVRY

SCIENTIFIC COOPERATION

IN-LICENSING

OUT-LICENSING

Filtrer par

COVID-19, how we adapt and respond to the situation.

New publication of a large French clinical trial evaluating Ostenil Plus in osteoarthritis

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

TRB Pharma Brazil awarded the Cândido Fontoura Necklace of Pharmaceutical Industry Merit

The MEIN AUGE reminder mobile application for your eye drops is now available